KLF5 and cancer: Importantly, our data reveal that the AGE–KLF5–KLHL13–CUL3 axis specifically regulates CEP57L1 without affecting its paralog CEP57 (Figs. 3E and S2A), highlighting a nonredundant and pathway-specific role for CEP57L1 in this diabetic cancer context.